| The PHARLEX® Newsletter was developed specifically for the business development minded executive focused on human therapeutics. Once per month by email, it provides a summary of relevant deals as well as information about personnel changes, ie. topics that are pertinent and useful for anyone interested in pharma and biotech deal making.
The PHARLEX® newsletter also features a selected business opportunity that may be of interest and great value to you, as well as a few noteworthy “discoveries” from the scientific arena.
From subscribers, we welcome announcements concerning deals and personnel changes in the area of licensing and business development, as well as information about specific licensing opportunities, which will be considered for free publication in the newsletter.
|